‘Appalled to see this study receive any attention at all’: Biotivia MD hits back at new Chianti resveratrol study
A new study that concludes that high intakes of resveratrol may not reduce a person’s risk of cardiovascular disease or cancer has ‘very little to offer in the way of new or compelling information’, says the managing director of Biotivia.